Home 2023 February

Monthly Archives: February 2023

News

Ligand to acquire APEIRON Biologics for $100 million

Ligand Pharmaceuticals has entered into a definitive agreement to acquire APEIRON Biologics, which holds royalty rights to QARZIBA (dinutuximab beta) for the treatment of...

Tagrisso with chemotherapy approved in EU as new 1st-line treatment for patients with EGFR-mutated...

AstraZeneca’s Tagrisso (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy has been approved in the European Union (EU) for the 1st-line treatment of adult...

FDA approves Roche’s Vabysmo prefilled syringe for three leading causes of vision loss

The United States Food and Drug Administration (US FDA) has approved Roche's Vabysmo (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for use in the...